-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Impact factor and its role in academic promotion
Other
(6634) Total Article Views
Authors: Richard Russell, Dave Singh
Published Date July 2009
Volume 2009:4 Pages 265 - 266
DOI: http://dx.doi.org/10.2147/COPD.S6533
Richard Russell,1 Dave Singh2
1Wrexham Park Hospital, Berkshire, UK; 2Northwest Lung Research Centre, South Manchester University Hospitals Trust, Manchester, UK
This statement was adopted unanimously at the May 17, 2009 meeting of the International Respiratory Journal Editors Roundtable.
In our collective experience as editors of international peer-reviewed journals, we propose that the impact factor calculated for individual journals should not be used as a basis for evaluating the significance of an individual scientist’s past performance or scientific potential. There are several reasons not to equate the impact factor of a journal in which the scientist publishes with the quality of the scientist’s research.
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Other articles by Dr Richard Russell
Readers of this article also read:
- Meet Dr Richard Russell at ATS 2013
We invite you to meet Dr Richard E Russell at the Dove Medical Press booth 1437 on May 20th at 2pm. Dr Russell is the Founding Editor of IJCOPD.
- Journal Indexing
See where all the Dove Press journals are indexed.
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




